Lupus Research Alliance News
New Study Partly Funded by LRA Reveals Novel Lupus Drug Targets

NEW YORK, NY – May 29. Researchers partly funded by the Lupus Research Alliance (LRA) have found possible new targets for drugs to treat lupus after snapping the first close-up of a molecule that promotes inflammation. The molecule that Target Identification in Lupus (TIL) grant recipient Dr. Roger Greenberg at University of Pennsylvania and Dr. […] READ MORE

Discovering Lupus Heterogeneity

May 22, 2019 Lupus is heterogeneous, meaning that symptoms are many and vary widely from patient to patient — one person may develop a rash, while another may have high blood pressure, joint pain, and anemia. About two thirds of adults with lupus have above-normal levels of immune system molecules called type I interferons that […] READ MORE

LRA Researchers Reveal New Drug Targets at Leading Immunology Conference

May 22, 2019 Data presented by several Lupus Research Alliance-funded scientists at the recent American Association of Immunologists Annual Meeting suggests many  avenues for new lupus treatments. Some scientists presented data posing new targets for drug development, while others have discovered cells that suppress the immune response and could be harnessed as treatments. Reining in […] READ MORE

Celebrate Clinical Trials Day May 20!

May 20, 2019 It’s Clinical Trials Day when the Lupus Research Alliance recognizes all the people we support who advance clinical research – scientists who identify and develop potential ways to diagnose, monitor and treat lupus,  researchers who design and conduct the studies to test these methods, and the volunteers who take part in the […] READ MORE

LRA Board Member Brenda Blackmon Honored by Caribbean Tourism Organization

May 16, 2019 We are proud to share that Brenda Blackmon, an active member of our Board of Directors, was named “Distinguished Friend of the Caribbean” by the Caribbean Tourism Organization. The award will be given at the Caribbean Tourism Industry Awards gala June 6  at the Wyndham New Yorker (481 Eighth Avenue) during Caribbean […] READ MORE

Illuminating the Microbiome’s Role in Lupus

May 15, 2019 One of the biggest questions in lupus is why the immune system tries to destroy patients’ own tissues. But in the last few years, researchers have learned that certain microbes living inside our bodies may trigger these attacks. Scientists supported by the Lupus Research Alliance (LRA) have made many of the key […] READ MORE

New Potential Treatment Approach for Cutaneous Lupus

May 14, 2019 Immune cells sneak into the skin and cause inflammation in patients with cutaneous lupus, the form of the disease that affects the skin. Now, Lupus Research Alliance Target Identification in Lupus (TIL) grant recipient Dr. Jillian Richmond of the University of Massachusetts Medical School in Worcester and her colleagues have shown that […] READ MORE

Racial Disparities in Rates of Death Among People with Lupus, Finds CDC Study

May 10, 2019 New research results from Emory University and the Centers for Disease Control and Prevention (CDC) found that while survival rates for people with systemic lupus erythematosus (SLE) have improved overall, the rate of death was significantly higher among black patients with SLE than whites, and death occured at a younger age. Researchers […] READ MORE

A Tough Childhood Linked to Poor Adult Health and Immune System Disorders Like Lupus

May 9, 2019 New study results published in Arthritis Care & Research found that “adverse childhood experiences” are more common among people with lupus. In the University of California San Francisco study, adverse childhood experiences were categorized as abuse, neglect, and/or household challenges. Among people with lupus, 63.2 percent had at least one adverse childhood […] READ MORE

LRA Grant Leads to New Drug Candidate RSLV-132

May 10, 2019 Grant support from the Lupus Research Alliance (then ALR) supported early work that led to a potential new drug, RSLV-132. In lupus, antibodies can target DNA’s chemical cousin RNA, which performs a variety of jobs in cells. When these antibodies encounter an RNA molecule, they attach to it, forming clusters that can […] READ MORE

Learn and connect with our community!